MedTrace Logo

Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers

NCT02965066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2016-11-16

No results posted yet for this study

Summary

The aim of the study is to test the performance and safety of a newly developed intermittent catheter in healthy volunteers.

Conditions

  • Incontinence, Urinary

Interventions

DEVICE

Coloplast Test Catheter

Newly developed intermittent catheter

DEVICE

Coloplast Speedicath

Marketed Coloplast Speedicath catheter

Sponsors & Collaborators

  • Coloplast A/S

    lead INDUSTRY

Principal Investigators

  • Per Bagi, MD · MD at the clinic of urology at Rigshospitalet

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Denmark

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02965066 on ClinicalTrials.gov